Nanotechnology-based drug delivery in mucosal immune diseases: hype or hope?
نویسندگان
چکیده
منابع مشابه
Immune therapy for breast cancer in 2010-hype or hope?
The identification of numerous breast cancer antigens has generated increasing enthusiasm for the application of immune-based therapies in breast malignancies. Although the use of monoclonal antibodies has revolutionized the "targeted therapy" of breast cancer, and the immunomodulatory effects of bisphosphonates continue to be evaluated, few studies to date have demonstrated widespread utility ...
متن کاملPharmacogenomics: Hope or Hype?
Much has been made of the potential for personalnot altruistic companies. Incyte Inc. alone holds US ised medicine, where a genomic screen of a patient patents on more than 350 genes and has an estimated could determine which drugs will work and be free of 6,500 applications pending with 10 more applied for side effects in an individual. Much of the hope based each week [3]. They hope to make p...
متن کاملMesenchymal stem cells in autoimmune diseases: hype or hope?
Intervention with mesenchymal stem cells (MSCs) represents a promising therapeutic tool in treatment-refractory autoimmune diseases. A new report by Schurgers and colleagues in a previous issue of Arthritis Research & Therapy sheds novel mechanistic insight into the pathways employed by MSCs to suppress T-cell proliferation in vitro, but, at the same time, indicates that MSCs do not influence T...
متن کاملThe relationship between periodontitis and systemic diseases - hype or hope?
Investigations have definitely acknowledged a clinically relevant two-way relationship between periodontitis and certain systemic diseases and conditions, which are significant for the dentist in the daily practice and for a physician as well. This review article yields the most up-to-date information on the role of periodontal diseases in systemic diseases, that include cardiovascular diseases...
متن کاملNanotechnology-Based Drug Delivery/Treatment Methods for Ischemic Heart Diseases
Ischemic heart conditions are some of the most prevalent disorders in the United States. These diseases also cause a significant number of mortalities each year. Despite considerable advances in treatment of the ischemic and infarct heart, many patients still develop complications and often progress to heart failure. These outcomes are typically related to factors such as the inability to deliv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Mucosal Immunology
سال: 2011
ISSN: 1933-0219,1935-3456
DOI: 10.1038/mi.2011.49